Incidence of Hypersensitivity Reactions to Carboplatin or Paclitaxel in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With or Without BRCA1 or BRCA2 Mutations

The association of BRCA mutation status with hypersensitivity reactions (HSRs) to carboplatin has gained interest in recent years, particularly in patients with ovarian, fallopian tube, and primary peritoneal cancer. The primary objective of this study is to determine whether the presence of BRCA mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Andrew, Frahm, Corey, Jeter, Joanne M., Abraham, Ivo, Chambers, Setsuko K., Cragun, Janiel M., McBride, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779569/
https://www.ncbi.nlm.nih.gov/pubmed/33457057
http://dx.doi.org/10.6004/jadpro.2019.10.5.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779569/
https://www.ncbi.nlm.nih.gov/pubmed/33457057
http://dx.doi.org/10.6004/jadpro.2019.10.5.2

Ejemplares similares